Xiaoyukang Jiaonang Promotes the Degradation of Hypoxia-Inducible Factor 1α and Antiangiogenesis and Anti-Inflammation in Chronic Subdural Hematoma Rat Model

Xiaoyukang Jiaonang (XYK) is a Chinese patent medicine approved by the National Medical Product Administration which is used to treat intracranial hematoma in China. In this study, we observed the molecular mechanism of XYK in hypoxia-inducible factor 1α (HIF-1α), inflammation and angiogenesis of ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jialin, Dong, Xiaoke, Li, Zhonghao, Wang, Gesheng, Zhou, Yujia, Liu, Chongchong, Wang, Kaiyue, Li, Lili, Liu, Jinmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165346/
https://www.ncbi.nlm.nih.gov/pubmed/32328124
http://dx.doi.org/10.1155/2020/2305017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165346/
https://www.ncbi.nlm.nih.gov/pubmed/32328124
http://dx.doi.org/10.1155/2020/2305017

Ejemplares similares